CSIMarket
 
Integrated Biopharma Inc  (INBP)
 
Price: $0.1800 $0.00 0.000%
Day's High: $0.18000000715255737 Week Perf: 0.00
Day's Low: $ 0.18 30 Day Perf: 12.5 %
Volume (M): 0 52 Wk High: $ 0.42
Volume (M$): $ 0 52 Wk Avg: $0.26
Open: $0.18 52 Wk Low: $0.14



 Market Capitalization (Millions $) 6
 Shares Outstanding (Millions) 31
 Employees 50
 Revenues (TTM) (Millions $) 47
 Net Income (TTM) (Millions $) -2
 Cash Flow (TTM) (Millions $) 3
 Capital Exp. (TTM) (Millions $) 0

Business Description


Integrated Biopharma Inc. is a publicly traded company based in the United States that operates in the biopharmaceutical industry. The company focuses on research, development, and production of specialty ingredients and raw materials for the health and nutritional industry. Integrated Biopharma specializes in the production of botanical extracts, dietary supplements, vitamins, and other natural health products. The company is committed to high quality and sustainable practices in its production processes. With a strong customer base, Integrated Biopharma Inc. aims to provide innovative and effective solutions to support the health and well-being of individuals worldwide.


   Company Address: 225 Long Ave. Hillside 7205 NJ
   Company Phone Number: 319-6962   Stock Exchange / Ticker: INBP


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ABBV        0.38% 
BMY        0.36% 
JNJ        2.68% 
LLY   -2.15%    
MRK        1.33% 
PFE        1.75% 
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.12
Price to Sales (Expected) -
Price to Book 0.29
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.05
Working Capital Ratio 3.25
Leverage Ratio (MRQ) 0.4
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.07 $
Revenues (TTM) 1.52 $
Cash Flow (TTM) 0.09 $
Cash 0.19 $
Book Value 0.61 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 944,820
Net Income per Employee (TTM) -33,080
Receivable Turnover Ratio (TTM) 11.34
Inventory Turnover Ratio (TTM) 4.96
Asset Turnover Ratio (TTM) 1.88

Profitability Ratios Current
Gross Margin (MRQ) -2.84 %
Operating Margin (MRQ) -11.16 %
Net Margin (MRQ) -8.61 %
Net Cash Flow Margin (MRQ) 5.27 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Integrated Biopharma Inc's Segments
Europe    20.1 % of total Revenue
Contract Manufacturing    101.02 % of total Revenue
Other Nutraceutical Business    2.92 % of total Revenue
UNITED STATES    83.83 % of total Revenue
UNITED STATES Contract Manufacturing    80.91 % of total Revenue
UNITED STATES Other Nutraceutical Business    2.92 % of total Revenue
Non-US    20.52 % of total Revenue
Non-US Contract Manufacturing    20.1 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.